Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors

[Image: see text] Current drugs against the influenza A virus (IAV) act by inhibiting viral neuraminidase (NA) enzymes responsible for the release of budding virions from sialoglycans on infected cells. Here, we describe an approach focused on a search for inhibitors that reinforce the protective fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Miriam, Senaati, Hooman P., Fisher, Christopher J., Huang, Mia L., Gagneux, Pascal, Godula, Kamil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084083/
https://www.ncbi.nlm.nih.gov/pubmed/27800553
http://dx.doi.org/10.1021/acscentsci.6b00191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084083/
https://www.ncbi.nlm.nih.gov/pubmed/27800553
http://dx.doi.org/10.1021/acscentsci.6b00191

Ejemplares similares